CVS Health stock analysis
CVS Health passes 5 of 8 fundamental tests, a score of 6/10. On the daily chart it is in an uptrend, RSI 58, 17% below its 52-week high: uptrend, no fresh entry: wait for a pullback or breakout. Its own volatility puts the likely range at $84.26–$101.24 a month from now and $67.20–$126.94 in a year (68% bands).
Fundamentals 6/10
- Market cap
- $118.1 B
- P/E · forward
- 24.3 · 10.8
- PEG · P/B
- 0.2 · 1.5
- ROE · net margin
- +6% · +1%
- Revenue · earnings growth
- +7% · +189%
- Debt / equity
- 96%
- Dividend · beta
- 2.9% · 0.6
- Next results
- 4 Nov 2026
- ✕ ROE above 15%
- ✕ Net margin above 10%
- ✕ Revenue growing over 10%
- ✓ Earnings growing
- ✓ Debt/equity under 100%
- ✓ Positive free cash flow
- ✓ Forward P/E under trailing (earnings expected up)
- ✓ PEG under 2
Swing technicals (daily)
- Trend
- up · 50d above 200d
- RSI(14)
- 58
- 20 / 50 / 200-day avg
- $87.65 / $91.72 / $88.18
- 20-day breakout
- above $92.64 · below $84.23
- ATR(14)
- $2.29 (2.5% a day)
- 52-week range
- $69.51 – $110.68
- Return 3m · 6m · 1y
- -14% · +19% · +12%
What the price could do
| In | Likely range (68%) |
|---|---|
| 1 mo | $84.26 – $101.24 (-9% / +10%) |
| 3 mo | $78.78 – $108.28 (-15% / +17%) |
| 6 mo | $73.76 – $115.65 (-20% / +25%) |
| 1 year | $67.20 – $126.94 (-27% / +37%) |
Analysts (25): strong buy, mean target $115.48 (+25%)
From its own volatility (32% a year), no drift assumed: what its swings allow, not a forecast.
CVS Health news · last two days
News lean: Neutral- 28h agoCVS Caremark Is Transforming the Health Care ExperienceACCESS Newswire
- 31h agoCVS settlement claim deadline is a month away. How to get moneyUSA TODAY
- 44h agoCVS Health (CVS) Exceeds Market Returns: Some Facts to ConsiderZacks
- 2d agoCVS Health collaborates with The Midlife Collective to redefine a woman's midlife health journeyPR Newswire
- 2d agoCVS Health - Early Detection Matters: Finding Heart Health Risks EarlierACCESS Newswire
- 3d agoCVS Settles DOJ Opioid Case for $315 Million: Here’s What It Means for the StockTIKR
- 3d agoCVS Pharmacy(R) Celebrates Opening of First Pharmacy-Focused Location in Boston AreaACCESS Newswire
- 3d agoCVS vs. ALHC: Which Medicare Advantage Stock Is the Better Pick Now?Zacks
- 4d agoCVS Agrees to $315M Settlement in Department of Justice Opioid Lawsuit Without Admitting FaultFirst for Money
- 4d agoCVS agrees to $315M DOJ settlement, enhanced DEA prescription oversightInvesting.com
Its order flow and footprint, the AI read of every headline, the expected move, and your own holdings beside it, with your broker connected.
Information and analytics for education only, not investment advice or a recommendation to buy or sell. Alephix Intelligence is not registered with SEBI as an investment adviser or research analyst. Prices may be delayed; figures come from public market data.